Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Green Star Products: New Research Data Indicates 99.9% Effective Against the COVID-19 Virus
Green Star Products, IncDecember 18, 2020 GMT
SALT LAKE CITY, UT, Dec. 18, 2020 (GLOBE NEWSWIRE) Green Star Products, Inc. (USOTC: GSPI) today announced it received new data from a US Federally Accredited Laboratory stating, “In three replications at 3% and 10% concentration [of normal dosage of Viro Spectrum Shield], 100% of the cells were protected from signs of infection by the SARS-CoV-2 [COVID-19] virus,
in vitro ”.
Additionally, Viro Spectrum Shield (VSS) was specifically tested and found to be effective against the COVID-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses
Green Star Products Signs Covid-19 Distribution Contract
SALT LAKE CITY, UT, Dec. 14, 2020 (GLOBE NEWSWIRE) Last Friday, December 11, 2020, Joseph LaStella, President of Green Star Products, Inc. (OTC: GSPI) announced he signed a Distribution Contract with Biotech Research, LLC, to market/sell their Broad-Spectrum Antiviral Product, called Viro Spectrum Shield (VSS), in several South American countries.
VSS has been tested by a US Federally Accredited Laboratory and has been successfully proven to inhibit SARS-CoV-2 (Covid-19) virus
in vitro.
VSS was specifically tested and found to be effective against the Covid-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses
Share:
SALT LAKE CITY, UT, Dec. 11, 2020 (GLOBE NEWSWIRE) Today, Joseph LaStella, President of Green Star Products, Inc. (OTC:GSPI) announced he has signed a Distribution Contract with Biotech Research, LLC, to market/sell their Broad-Spectrum Antiviral Product, called Viro Spectrum Shield (VSS), in several South American countries.
VSS has been tested by a US Federally Accredited Laboratory and has been successfully proven to inhibit SARS-CoV-2 (Covid-19) virus
in vitro.
VSS was specifically tested and found to be effective against the Covid-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses
in vitro, which demonstrates its Broad-Spectrum Antiviral Capability. VSS was also tested and found to be non-toxic